Moving the HME Industry Forward

Respiratory/Sleep

Philips Respironics Preps for Medtrade After Splash at SLEEP

June 9, 2014

MINNEAPOLIS – A new study presented at SLEEP 2014 by Philips Respironics (Booth #1711 at Medtrade, scheduled for Oct 20-23, 2014) concluded that patients using the SleepMapper mobile app and web-based ­solution achieved a 22% higher positive airway pressure (PAP) therapy adherence rate than non-users. The results of the study further the evidence that patient engagement in care can lead to behavioral change and ultimately, better results and healthier populations.

“Healthcare is changing, and if you’re in the business of making people healthier, you’re in the business of behavior change,” said Dr. Mark Aloia, senior director of Global Clinical Research for Philips Healthcare. “Study results of SleepMapper demonstrate that technology can shape how patients respond to PAP therapy by improving engagement and motivation and leading them to better treatment for their chronic condition.”

To test the effectiveness of SleepMapper, researchers randomly analyzed more than 15,000 patients from the Philips Respironics EncoreAnywhere database and compared adherence and usage rates between those who were provided with SleepMapper upon initial PAP setup, and those who were not. Patients who were provided with SleepMapper achieved a 78% adherence rate based upon the CMS guidelines, compared to the average 56% compliance rate among patients who were not provided with SleepMapper.

In addition, patients who were provided with SleepMapper slept an average of 1.4 hours longer on PAP than patients who were not provided with SleepMapper. As for new PAP patients struggling to manage and accept their therapy, 33% of those who engaged with SleepMapper were able to meet adherence guidelines within 90 days, compared to just 11% who were not provided with the tool.

Designed by a team of sleep and psychological experts from Philips Respironics with the goal of improving therapy adherence by changing patient behavior, SleepMapper is an interactive mobile and web-based application that enables patients to take a more active role in their PAP therapy and better utilize their PAP device for more effective treatment.

SleepMapper engages patients by providing them with feedback on their individual adherence and therapy information, while also using empirically-tested behavior change therapies to motivate patients and keep them interested. SleepMapper works with Philips Respironics’ EncoreAnywhere patient management system and most of its System One devices to offer a complete therapy and compliance package.

Additional sleep-related companies scheduled to exhibit at Medtrade include:
Battery Power Solutions – Booth #2245
Contour Products Inc – Booth #1025
Drive Medical – Booth #1617
Eastex Products Inc – Booth #2360
Fisher & Paykel Healthcare – Booth #1644
Glenn Medical Systems Inc – Booth #1029
Hudson Medical – Booth #1836
Inventory Solutions Inc – Booth #1237
Linak US Inc – Booth #1852
Nonin Medical Inc – Booth #1212
Philips Respironics Inc – Booth #1711
RemZzzs – Booth #1756
ResMed – Booth #1317
Roscoe Medical – Booth #1516
Sleep Nation Inc – Booth #2464
Transfer Master Products Inc – Booth #2252
U-Sleep – Booth #1330

Medtrade takes place Oct 20-23, 2014, at the Georgia World Congress Center in Atlanta. Early registration for attendees will begin on Monday, June 16. Check the June 16 Medtrade Monday for complete details. Go to www.medtrade.com for more information about the nation’s premiere HME trade show.